GFA
PFE icon

Godfrey Financial Associates’s Pfizer PFE Stock Holding History

Godfrey Financial Associates’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.1K Buy
1,041
+7
+0.7% +$183 0.02% 326
2026
Q1 		$29K Buy
1,034
+7
+0.7% +$186 0.02% 291
2025
Q4 		$25.6K Buy
+1,027
New +$25.9K 0.02% 300

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Godfrey Financial Associates's PFE Position: Q2 2026 in Review

Godfrey Financial Associates increased its Pfizer (PFE) stake by 0.68% in Q2 2026, buying an estimated $183 and bringing the position to 1,041 shares worth $25.1K. The position accounts for 0.02% of the portfolio, ranked #326.

Godfrey Financial Associates first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $29K in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Godfrey Financial Associates held 1,041 shares of Pfizer worth $25.1K as of Q2 2026.
  • Godfrey Financial Associates bought 7 Pfizer shares in Q2 2026, an estimated $183.
  • Pfizer made up 0.02% of Godfrey Financial Associates's portfolio in Q2 2026, its #326 holding.
  • Godfrey Financial Associates first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • Godfrey Financial Associates's Pfizer position peaked at $29K in Q1 2026.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Godfrey Financial Associates's 13F filing for Q2 2026, filed 11 Aug 2026.